These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3546209)

  • 1. A correctable complication of advanced congestive heart failure.
    Valle GA; Lemberg L
    Heart Lung; 1987 Mar; 16(2):224-6. PubMed ID: 3546209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
    Rossi J; Bayram M; Udelson JE; Lloyd-Jones D; Adams KF; Oconnor CM; Stough WG; Ouyang J; Shin DD; Orlandi C; Gheorghiade M
    Acute Card Care; 2007; 9(2):82-6. PubMed ID: 17573581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
    Gheorghiade M; Niazi I; Ouyang J; Czerwiec F; Kambayashi J; Zampino M; Orlandi C;
    Circulation; 2003 Jun; 107(21):2690-6. PubMed ID: 12742979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyshomeostasis of serum sodium concentration in congestive heart failure.
    Haley H; Ploth DW
    Am J Med Sci; 2010 Jul; 340(1):42-7. PubMed ID: 20610972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of hyponatremia with angiotensin-converting enzyme inhibitors in patients with congestive heart failure.
    Elisaf M; Theodorou J; Pappas C; Siamopoulos K
    Cardiology; 1995; 86(6):477-80. PubMed ID: 7585758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loop diuretics for heart failure-associated hyponatremia.
    Lapsia V; Kazory A
    Am J Med; 2010 Aug; 123(8):e5-6. PubMed ID: 20670712
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyponatremia in congestive heart failure.
    Oren RM
    Am J Cardiol; 2005 May; 95(9A):2B-7B. PubMed ID: 15847851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating hyponatremia in heart failure.
    Goldsmith SR
    Curr Cardiol Rep; 2006 May; 8(3):204-10. PubMed ID: 17552085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urea treatment for water retention in hyponatremic congestive heart failure.
    Cauchie P; Vincken W; Decaux G
    Int J Cardiol; 1987 Oct; 17(1):102-4. PubMed ID: 3666993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The sick-cell syndrome].
    Japa J; Kardaszewicz S; Staś J; Gburek Z
    Pol Tyg Lek; 1971 Aug; 26(33):1283-5. PubMed ID: 5093969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of a normal sodium diet in the diuretic treatment of refractory cardiac insufficiency].
    Sánchez Torres G; Posadas C; Tena I; Boyer JL; Enríquez C
    Arch Inst Cardiol Mex; 1982; 52(6):507-15. PubMed ID: 7159133
    [No Abstract]   [Full Text] [Related]  

  • 15. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
    Libetta C; Sepe V; Zucchi M; Pisacco P; Cosmai L; Meloni F; Campana C; Rampino T; Monti C; Tavazzi L; Dal Canton A
    Nephrol Dial Transplant; 2007 Jul; 22(7):2013-9. PubMed ID: 17298996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition.
    Packer M; Medina N; Yushak M
    Ann Intern Med; 1984 Jun; 100(6):782-9. PubMed ID: 6326629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium, water, and congestive heart failure.
    Hamilton RW; Buckalew VM
    Ann Intern Med; 1984 Jun; 100(6):902-4. PubMed ID: 6372567
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR
    Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.